Salud financiera de hoja de balance de Werewolf Therapeutics
Salud financiera controles de criterios 5/6
Werewolf Therapeutics tiene un patrimonio de los accionistas total de $111.4M y una deuda total de $39.3M, lo que sitúa su ratio deuda-patrimonio en 35.3%. Sus activos y pasivos totales son $174.8M y $63.5M respectivamente.
Información clave
35.3%
Ratio deuda-patrimonio
US$39.32m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$134.34m |
| Patrimonio | US$111.37m |
| Total pasivo | US$63.46m |
| Activos totales | US$174.83m |
Actualizaciones recientes sobre salud financiera
Is Werewolf Therapeutics (NASDAQ:HOWL) A Risky Investment?
Jan 19
We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
May 06Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Jan 27We're Not Very Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Rate
Oct 24We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
Jul 08Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Mar 24Recent updates
Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space
Apr 04Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Feb 07Is Werewolf Therapeutics (NASDAQ:HOWL) A Risky Investment?
Jan 19There's No Escaping Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Muted Revenues Despite A 28% Share Price Rise
Dec 09Analysts Just Shipped A Captivating Upgrade To Their Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Estimates
Sep 30Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 13We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
May 06Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Jan 27We're Not Very Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Rate
Oct 24We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
Jul 08Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Mar 24Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Dec 09Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($138.4M) de HOWL superan a sus pasivos a corto plazo ($19.4M).
Pasivo a largo plazo: Los activos a corto plazo de HOWL ($138.4M) superan a sus pasivos a largo plazo ($44.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: HOWL tiene más efectivo que su deuda total.
Reducción de la deuda: No se dispone de datos suficientes para determinar si el ratio deuda-patrimonio de HOWL se ha reducido en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: HOWL tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.
Pronóstico de cash runway: HOWL dispone de suficiente cash runway para 2.7 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 21.5% cada año.